Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
New phase-III data support Roche’s Tecentriq in early-stage lung cancer
As published in The Lancet, Tecentriq is the first and only cancer immunotherapy to demonstrate positive phase-III results in the…
COVID-19 shapes Indian pharma deals landscape, reveals GlobalData report
Between 2019 and 2020, the deal number increased by 22 per cent, likely triggered by the COVID-19 pandemic
India to resume export of surplus COVID vaccines in October-December quarter
Addressing the media, Health Minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and…
Mirati drug combination shrinks tumours in 39 per cent of colon cancer patients in study
Adagrasib targets a mutated form of a gene known as KRAS that occurs in around 13 per cent of non-small cell lung cancers, three…
“Make in India” to fuel four-times growth in biosimilars and vaccines by 2026: CII-Kearney report
The report outlines that India is home to only eight per cent of the world’s biopharmaceutical market
Is your instrument compliant after every repair?
Regulated laboratories must be able to demonstrate the suitability of analytical instruments during audits and inspections.…
IPC releases guidance document on Good Documentation Practices
The document intends to provide general guidance to all users of the IP to help in ensuring proper compliance with the IP…
Booster shots necessary to beat COVID-19 virus, says Dr Fauci
Pfizer made the proposal in a 52-page presentation to the US FDA, which included data from the recent Israeli study, which showed…
US sees surge in demand for monoclonal antibodies to treat COVID
Overall, the demand for monoclonal antibody treatment, lab-made antibodies given to a person that help their immune system stop…
A Superstar marriage?
Chandru Chawla, a pharma veteran, opines that Biocon and SII coming together is a milestone event in the evolution of Indian…